Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Nuwellis, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 6 | 7 | +1 |
| Shares | 35.4K | 82.5K | +47.0K (+132.8%) |
| Value | $42.2K | $91.5K | +$49.4K (+117.1%) |
New holders (4)
Institutions that held Nuwellis, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 30,806 | $34.2K | 0.00% |
| UBS Group AG | 23,236 | $25.8K | 0.00% |
| Citadel Advisors LLC | 11,771 | $13.1K | 0.00% |
| SBI Securities Co., Ltd. | 547 | $607 | 0.00% |
Sold out (3)
Institutions that held Nuwellis, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| HRT Financial LP | 15,127 | $18.0K |
| Morgan Stanley | 312 | $371 |
| JPMorgan Chase & Co | 1 | $1 |